We found 4 mohs skin cancer surgeons who accept Platinum Navigate Plus 0 near Philadelphia, PA.

Showing 1-4 of 4
Dr. Ernest Alfred Benedetto, MD
Specializes in MOHS-Micrographic Surgery
1200 Locust Street
Philadelphia, PA
 

Dr. Ernest Benedetto is a MOHS-micrographic surgery specialist. He is conversant in Italian. Dr. Benedetto's hospital/clinic affiliations include Mercy Fitzgerald Hospital and Crozer-Keystone Health System. After attending the University of Rome Faculty of Medicine and Surgery for medical school, he completed his residency training at Cleveland Clinic. He is rated highly by his patients. He is an in-network provider for Coventry, United Healthcare HSA, and United Healthcare HMO, in addition to other insurance carriers.

Read more
No Photo
Specializes in Pediatric Dermatology, Dermatopathology, MOHS-Micrographic Surgery
3900 Woodland Avenue
Philadelphia, PA
 

Dr. Carmen Campanelli specializes in pediatric dermatology, dermatopathology, and MOHS-micrographic surgery and practices in Yardley, PA and Philadelphia, PA. Dr. Campanelli studied medicine at Thomas Jefferson University, Jefferson Medical College. Dr. Campanelli is in-network for United Healthcare Platinum, United Healthcare Navigate, and Aetna HSA, in addition to other insurance carriers. Dr. Campanelli's hospital/clinic affiliations include Philadelphia VA Medical Center and St. Mary Medical Center. Dr. Campanelli is open to new patients.

Read more
Dr. Jeremy Robert Etzkorn, MD
Specializes in MOHS-Micrographic Surgery
3400 Civic Center Boulevard; South Pavilion, 1st Floor
Philadelphia, PA
 

Dr. Jeremy Etzkorn works as a mohs skin cancer surgeon. Dr. Etzkorn is rated 4.0 stars out of 5 by his patients. His areas of expertise include facial reconstruction, nail biopsy, and hyaluronic acid injections. He honors Blue Cross/Blue Shield, Coventry, and TRICARE, as well as other insurance carriers. Dr. Etzkorn graduated from Washington University in St. Louis School of Medicine and then he performed his residency at Tampa General Hospital. He is professionally affiliated with Hospital of the University of Pennsylvania (HUP).

Read more

Clinical interests: Hyaluronic Acid Injections, Botox Injection, Eyelid Problems, Nail Biopsy, Reconstructive Surgery, ... (Read more)

Dr. Paul Xavier Benedetto, MD
Specializes in MOHS-Micrographic Surgery
1200 Locust Street
Philadelphia, PA
 

Dr. Paul Benedetto specializes in MOHS-micrographic surgery. Before completing his residency at Cleveland Clinic, Dr. Benedetto attended medical school at Thomas Jefferson University, Jefferson Medical College. Coventry, United Healthcare HSA, and United Healthcare HMO are among the insurance carriers that Dr. Benedetto takes. Dr. Benedetto (or staff) is conversant in Spanish and Italian. Dr. Benedetto is affiliated with Mercy Fitzgerald Hospital and Crozer-Keystone Health System.

Read more

Conditions / Treatments

Gender

Insurance

New Patients

Medicare Patient Conditions

Medicare Patient Ethnicity

Additional Information

Distinctions

Foreign Language

Research

Online Communication

Practice Affiliation

Fellowship

Medical School

Residency

Years Since Graduation

What is MOHS-Micrographic Surgery?

Mohs micrographic surgery is a surgical treatment for skin cancer that was developed by Dr. Frederick Mohs in the 1930’s. It is the most effective technique for removing the most common types of skin cancer. For the two most common types of skin cancer, basal cell carcinoma and squamous cell carcinoma, Mohs has a 98-99% cure rate. The remarkable thing about Mohs is that it manages to be extremely good at removing all of the cancer cells while at the same time leaving behind most of the healthy tissue, so there is a smaller wound. This makes the procedure safer, speeds up the the recovery time, and minimizes scarring.

During Mohs surgery, skin around the cancer site is mapped out and removed in thin layers. Then each layer is examined under a microscope for cancer cells, while the surgery is in progress. If cancer cells are detected, the surgery continues and another layer is removed. If the skin is clear, the surgery can be stopped. This eliminates the guesswork for surgeons. There is no need to estimate the borders or roots of the cancer and no need to remove a margin of healthy tissue to ensure that all of the cancer is removed.

Even though Mohs has a high cure rate, is safer than other treatments, and takes less tissue, not every skin cancer is treated with Mohs. First, Mohs takes quite a bit longer than traditional surgery because each layer of skin must be carefully cut, prepped, and examined. It is also more expensive and may not always be covered by insurance. In addition, for smaller or less aggressive cancers that are easier to treat, the cure rate for non-Mohs treatments is close to that of Mohs; thus, the extra time and cost of Mohs might not be justified. Other kinds of skin cancer, such as melanoma, are hard to see under a microscope. Since melanoma is so dangerous, Mohs has traditionally not been used to treat it, as there is too much risk for missed cancer cells being left behind in the body. However, recent developments in stains (which make cancer cells more visible under a microscope) may change the role of Mohs in melanoma treatment.

Mohs microsurgery has changed the way doctors treat skin cancer in the past 80 years, and it continues to gain in popularity as it increases the effectiveness and safety of skin cancer treatment.